- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Ro-09-1978-000 | Ro-091978000 | Xeloda®
capecitabine is an approved drug (FDA (1998), EMA (2001))
Compound class: Synthetic organic
Comment: Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil (active agent). It is a thymidylate synthase inhibitor.
|Compound class||Synthetic organic|
|Approved drug?||Yes (FDA (1998), EMA (2001))|
|WHO Essential Medicine||WHO Essential Medicines List (EML) (22nd List, 2021). Access PDF version.
Click to view more information about the WHO Model Lists of Essential Medicines.
|International Nonproprietary Names|
|Ro-09-1978-000 | Ro-091978000 | Xeloda®|
|CAS Registry No.||154361-50-9|
|GtoPdb PubChem SID||178103405|
|Search Google for chemical match using the InChIKey||GAGWJHPBXLXJQN-UORFTKCHSA-N|
|Search Google for chemicals with the same backbone||GAGWJHPBXLXJQN|
|Search PubMed clinical trials||capecitabine|
|Search PubMed titles||capecitabine|
|Search PubMed titles/abstracts||capecitabine|
|UniChem Compound Search for chemical match using the InChIKey||GAGWJHPBXLXJQN-UORFTKCHSA-N|
|UniChem Connectivity Search for chemical match using the InChIKey||GAGWJHPBXLXJQN-UORFTKCHSA-N|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Capecitabine (links to external site)
Cat. No. 4799